TRDA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 119242 min ago

@ $14.49

Wydano: 13 vas. 2024 @ 16:30

Zwrot: -9.18%

Poprzedni sygnał: vas. 7 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 1.26 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases...

Stats
Dzisiejszy wolumen	38 162.00
Średni wolumen	79 571.00
Kapitalizacja rynkowa	442.19M
EPS	$0 ( 2024-03-18 )
Następna data zysków	( $-0.380 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-65.80
ATR14	$0.0680 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Kim Peter S	Buy	2 600	Common Stock
2024-03-28	Kim Peter S	Buy	1 512	Common Stock
2024-03-26	Kim Peter S	Buy	2 750	Common Stock
2024-03-25	Kim Peter S	Buy	3 180	Common Stock
2024-03-22	Kim Peter S	Buy	3 118	Common Stock

INSIDER POWER
70.20
Last 99 transactions
Buy: 995 092 \| Sell: 209 386

Wolumen Korelacja

Długi: 0.27 (neutral)

Krótki: -0.04 (neutral)

Signal:(53.214) Neutral

Entrada Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
GXGX	0.876
MTP	0.872
HOL	0.871
PEV	0.864
IMGN	0.861
EPSN	0.85
PLIN	0.847
THCB	0.842
LGMK	0.839
CBIO	0.839

10 Najbardziej negatywne korelacje
RAVN	-0.874
CSPI	-0.853
NECB	-0.85
CREC	-0.848
TBSAU	-0.848
GHIX	-0.846
HOFT	-0.842
ENTF	-0.842
FICV	-0.842
IVAC	-0.839

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entrada Therapeutics, Korelacja - Waluta/Towar

0.05
( neutral )

-0.48
( neutral )

0.00
( neutral )

0.14
( neutral )

0.48
( neutral )

-0.77
( moderate negative )

Entrada Therapeutics, Finanse

Annual	2023
Przychody:	$129.01M
Zysk brutto:	$126.17M (97.80 %)
EPS:	$-0.200

FY	2023
Przychody:	$129.01M
Zysk brutto:	$126.17M (97.80 %)
EPS:	$-0.200

FY	2022
Przychody:	$0
Zysk brutto:	$-1.90M (0.00 %)
EPS:	$-2.79

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.97

Financial Reports:

No articles found.

Entrada Therapeutics,

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Aktualne aktualizacje dla Entrada Therapeutics, [TRDA]

Upcoming Earnings Alert